Skip to content

Latest roundsacross Alphaneo coverage

AlphaneoAlphaneo
Menu
Get started

CompaniesOtherUpdated Oct 6, 2026

Celaid Therapeutics

Private. Celaid Therapeutics Inc. is a biotechnology startup originating from the University of Tokyo and the University of Tsukuba, with proprietary technology for the selective ex vivo expansion of hematopoietic stem cells (HSCs), which give rise to all blood cells.

Last round
JPY 400M Series B second close
Backed by
Not recorded
Launched
2020
People
3
Celaid TherapeuticsOpportunities are private
6 questions · about a minute · not a commitment
7 questions · private · nothing shared without consent
Watch

Overview

Updated Oct 6, 2026

Every fact carries a numbered source. Where we can't source something, it says so.

Identity fields from the company record are sourced where a source is recorded; those have no number.

Founded
20203
Website
celaidtx.com opens in a new tab4
Headquarters
Bunkyo-ku, Tokyo, Japan · as of 2026-10-042
Stage
Series B · as of 2026-10-042
Total raised
approximately JPY 3.42 billion · as of 2026-10-042
Sector
Not recorded
Geography
Bunkyo-ku, Tokyo, Japan

Funding

How much has Celaid Therapeutics raised?

Rounds and backers, each sourced.

Rounds

  1. 2026-10-04

    Series B second close · JPY 400M raised2

    Led by Not recorded

  2. 2025-10-07

    Series B first close · JPY 1.05B raised1

    Led by Not recorded

Backers

No backer recorded. Backers are the lead investors a sourced round names.

Opportunities For accredited investors

Ways to invest in this company through an Alphaneo vehicle, when one exists. This section looks the same on every company page until you have an accredited profile.

For accredited investors

Opportunities, terms and data rooms are shown to accredited investors. Creating a profile takes two minutes, and you’re notified first when anything opens.

No live opportunities right now. Accredited investors are notified first when one opens.

Create an accredited profile

A vehicle is never smaller than $1,000,000.

People

Who founded and leads Celaid Therapeutics?

Names and titles only, each sourced.

  • Yusuke InoueBoard Director, COO & CFO3
  • Asako UchiyamaBoard Director, CDO (Chief Development Officer) / General Manager of BD3
  • Nobuyuki ArakawaCo-founder, President and CEO3

Sources

Every claim on this page traces to one of these. The numbers match the citations above.

  1. 1
  2. 2
    Celaid Therapeutics Completes Second Close of Series B Financing Round opens in a new tabHeadquarters, Stage, Total raised, Funding · accessed Oct 6, 2026
  3. 3
  4. 4